The prognostic value of the C-reactive protein levels in HD patients with death risk from infection

Clinical Nephrology

Volumn 68, Issue 1, 2007, Pages 18-25

  Koch, M ^a,c   Haastert, B ^b   Trapp, R ^a  

^a and Metabolic Diseases   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c NONE   (Germany)

Author keywords

C reactive protein; Cause of death in dialysis; End stage renal disease; Infection prevalence

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; INFECTION; INFECTION RATE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; PROGNOSIS; REFERENCE VALUE; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SURVIVOR;

EID: 34447284264     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp68018     Document Type: Article

References (9)

1. Allon M, Depner TA, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, Gassman JJ, Kaufman AM, Kaysen GA, Lewis JA, Schwab SJ. Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study. J Am Soc Nephrol. 2003; 14: 1863-1870.
2. Anonymous. Causes of death. United States Renal Data System. Am J Kidney Dis. 1998; 32: S81-S88.
3. Avram MM, Fein PA, Paluch MM, Schloth T, Chattopadhyay J. Association between C-reactive protein and clinical outcomes in peritoneal dialysis patients. Adv Petit Dial. 2005; 21: 154-158.
4. Foley RN, Guo H, Snyder JJ, Gilbertson DT, Collins AJ. Septicemia in the United States dialysis population, 1991 to 1999. J Am Soc Nephrol. 2004; 15: 1038-1045.
5. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998; 339: 799-805.
6. Koch M, Trapp R, Kulas W, Grabensee B. Critical limb ischaemia as a main cause of death in patients with end-stage renal disease: a single-centre study. Nephrol Dial Transplant. 2004; 19: 2547-2552.
7. Reny JL, Vuagnat A, Ract C, Benoit MO, Safar M, Fagon JY. Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables. Crit Care Med. 2002; 30: 529-535.
8. Tripepi G, Mallamaci F, Zoccali C. Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol. 2005; 16 (Suppl 1): S83-S88.
9. Wang AY. Prognostic value of C-reactive protein for heart disease in dialysis patients. Curr Opin Invest Drugs. 2005; 6: 879-886.